Cargando…

Current and emerging immunotherapeutic approaches to the treatment of multiple myeloma

Multiple myeloma (MM) has a worldwide incidence of 1–5/100,000/year. Outcomes have improved significantly in recent years following incorporation of immunomodulatory drugs and proteasome inhibitors into standard-of-care regimes. MM is profoundly immunosuppressive, enabling immune evasion, proliferat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swan, Dawn, Lynch, Kevin, Gurney, Mark, O’Dwyer, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582283/ https://www.ncbi.nlm.nih.gov/pubmed/31244984 http://dx.doi.org/10.1177/2040620719854171

Ejemplares similares

Beyond DNA Damage: Exploring the Immunomodulatory Effects of Cyclophosphamide in Multiple Myeloma
por: Swan, Dawn, et al.
Publicado: (2020)

Immunotherapeutic and Targeted Approaches in Multiple Myeloma
por: Nadeem, Omar, et al.
Publicado: (2020)

New developments in the treatment of multiple myeloma – clinical utility of daratumumab
por: McEllistrim, Cian, et al.
Publicado: (2017)

Realizing Innate Potential: CAR-NK Cell Therapies for Acute Myeloid Leukemia
por: Gurney, Mark, et al.
Publicado: (2021)

Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma
por: Meyers, Daniel E., et al.
Publicado: (2017)

Minimal Residual Disease in Multiple Myeloma: Current Landscape and Future Applications With Immunotherapeutic Approaches
por: Kostopoulos, Ioannis V., et al.
Publicado: (2020)

Targeted Approaches to Inhibit Sialylation of Multiple Myeloma in the Bone Marrow Microenvironment
por: Natoni, Alessandro, et al.
Publicado: (2019)

SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments
por: Chu, Emily, et al.
Publicado: (2023)

Targeting the Pim kinases in multiple myeloma
por: Keane, N A, et al.
Publicado: (2015)

CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
por: Morandi, Fabio, et al.
Publicado: (2018)

Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?
por: Favreau, Mérédis, et al.
Publicado: (2016)

Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer
por: Daly, John, et al.
Publicado: (2019)

Current and Emerging Treatments for Multiple Myeloma
por: Schwartz, Rowena N., et al.
Publicado: (2008)

Current Immunotherapeutic Strategies for the Treatment of Glioblastoma
por: Dapash, Mark, et al.
Publicado: (2021)

Immunotherapeutic Approaches for Glioblastoma Treatment
por: Yaghi, Nasser K., et al.
Publicado: (2022)

Adoptive Immunotherapy and High-Risk Myeloma
por: Duane, Catherine, et al.
Publicado: (2023)

Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma
por: Swamydas, Muthulekha, et al.
Publicado: (2022)

Immunotherapeutic strategies targeting B cell maturation antigen in multiple myeloma
por: Fang, Yi, et al.
Publicado: (2021)

Current Immunotherapeutic Approaches in Pancreatic Cancer
por: Koido, Shigeo, et al.
Publicado: (2011)

Current Immunotherapeutic Approaches for Malignant Gliomas
por: Han, Myung-Hoon, et al.
Publicado: (2022)

Immunotherapeutics in Multiple Myeloma: How Can Translational Mouse Models Help?
por: Cooke, Rachel E., et al.
Publicado: (2019)

Current clinical immunotherapeutic approaches for head and neck cancer
por: Soto Chervin, Carolina, et al.
Publicado: (2016)

Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas
por: Poggio, Teresa, et al.
Publicado: (2018)

Bispecific Antibodies in Multiple Myeloma: Opportunities to Enhance Efficacy and Improve Safety
por: Swan, Dawn, et al.
Publicado: (2023)

Immunotherapeutic approaches to ovarian cancer treatment
por: Chester, Cariad, et al.
Publicado: (2015)

Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer
por: Allahverdiyev, Adil, et al.
Publicado: (2018)

Insights on Multiple Myeloma Treatment Strategies
por: Mateos, María-Victoria, et al.
Publicado: (2018)

Identification and validation of ecto-5' nucleotidase as an immunotherapeutic target in multiple myeloma
por: Ray, Arghya, et al.
Publicado: (2022)

Feeder Cells at the Interface of Natural Killer Cell Activation, Expansion and Gene Editing
por: Gurney, Mark, et al.
Publicado: (2022)

Risks and risk management in modern multiple sclerosis immunotherapeutic treatment
por: Klotz, Luisa, et al.
Publicado: (2019)

Immunotherapeutic and their immunological aspects: Current treatment strategies and agents
por: Jain, Mayank, et al.
Publicado: (2022)

Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses
por: Daly, John, et al.
Publicado: (2022)

Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020
por: Bobin, Arthur, et al.
Publicado: (2020)

Current and Emerging Treatment Options for Patients with Relapsed Myeloma
por: Castelli, Roberto, et al.
Publicado: (2013)

Immunotherapeutic approaches for hepatocellular carcinoma
por: Longo, Vito, et al.
Publicado: (2017)

Immunotherapeutic Approaches in Ovarian Cancer
por: Yoon, Hyunho, et al.
Publicado: (2023)

Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions
por: Blum, Agnieszka, et al.
Publicado: (2018)

Current Advances and Future Prospects in Cancer Immunotherapeutics
por: DEDE, Zeynep, et al.
Publicado: (2023)

New Immunotherapeutic Approaches for Glioblastoma
por: Vázquez Cervantes, Gustavo Ignacio, et al.
Publicado: (2021)

The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance
por: Ferguson, Ian D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_391lkact1ld5jhuormfs6o4u5m